Article
Arenobufagin causes ferroptosis in human gastric cancer cells by increasing rev-erbα expression
8 Nov 2022
Abstract excerpt
Background and aims: Gastric cancer is the fifth most diagnosed malignant tumor worldwide with limited effective chemotherapy. Ferroptosis is a new type of programmed cell death, which is becoming as a novel therapeutic target for tumors. Arenobufagin (ArBu) is a bufadienolide isolated from toad skin and venom, which exhibits broad-spectrum anti-tumor activity. It is unclear whether ArBu causes ferroptosis,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
